Islamic Republic of Iran


UNODC Iran facilitated a two-day training workshop on drug related data collection and analysis for experts from the Drug Control Headquarters of the Islamic Republic of Iran


UNODC Iran facilitated and organized a two-day training workshop on United Nations Procedures on Collection and Analysis of National Drug Related Data for UNODC Annual Report Questionnaire (ARQ) on 23-24 April 2018, in close collaboration with the Islamic Republic of Iran Drug Control Headquarters.

The purpose of organizing this workshop was to discuss data collection and research, and to present an overview of the global drug related data collections systems, namely Annual Report Questionnaire, and its data reporting obligations. The workshop was an opportunity to improve the engagement of the Drug Control Headquarters thematic departments to international affairs and reporting. It also brought into light the importance of transparent reporting at international level that can reflect Iran efforts in the field of drug supply and demand reduction.

The workshop was facilitated by Ms. Angela Me, Chief of Research and Trend Analysis Branch in UNODC Headquarters in Vienna. Senior officials and experts from the Islamic Republic of Iran Drug Control Headquarters, Prisons Organization and Ministry of Foreign Affairs, involved in the compilation of data for UNODC Annual Report Questionnaires participated in the workshop.

Annual Report Questionnaire is a global reporting tool completed by member states on drug situation in each country. It consists of four parts on legal and administrative aspects of the working of the treaties, progress in implementation of the Plan of Action and the Political Declaration, drug abuse and its health consequences and illicit drug cultivation, manufacture and trafficking.

On the second day of the training, Ms. Me (UNODC) visited the Iranian National Center for Addiction Study (INCAS). The Center is an example of world excellence for its clinical work on treatment for opioids, Amphetamine Type Stimulants and cannabis as well as clinical research and epidemiology.










For more information, you can contact:

Leila Ahmadi, Research and Liaison Officer,

Tel.: (+98-21) 88878377-81, ext. 127;